Changes in the expression of potassium channels regulate skeletal muscle development. The purpose of this study has been to investigate the expression profile and phamacological role of K v 7
INTRODUCTION
Skeletal muscle development is a multifactorial, highly controlled process involving the coordinated regulation of a large number of genes which allow proliferating myoblasts to withdraw from the cell cycle, to fuse in ordered arrays of large multinucleated myotubes, and to further differentiate into mature muscle fibers (Walsh and Perlman, 1997) .
Changes in the expression of potassium (K + ) channels appear to be associated with the myoblast to myotube transition (Cooper, 2001) . Following earlier reports on distinct voltage-sensitive K + channels being developmentally regulated in vivo (Lesage et al., 1992) , K + currents carried by ether-à-go-go (K v 10.1) (Bijlenga et al., 1998) and K IR 2.1 (Wieland and Gong, 1995; FischerLougheed et al., 2001 ) channels have been shown to play a specific role in determining the membrane hyperpolarization which occurs during the early phases of myoblast commitment and fusion in vitro. This phenomenon is believed to allow significant Ca 2+ influx through T-type voltage-gated Ca 2+ channels, thereby triggering the increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) necessary for myoblast fusion (Bijlenga et al., 2000) . Other K + channels, such as intermediate-conductance Ca 2+ -activated K + channels, appear to be down-regulated during myogenesis, although they do not play a significant role in myoblast proliferation (Fioretti et al.,
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5 excitability, functioning as a brake for repetitive action potential firing (Brown and Adams, 1980) .
In humans, mutations in the K v 7.1 gene are responsible for one form of long QT syndrome (LQTS-1), whereas mutations targeting K v 7.4 cause a rare form of non-syndromic autosomal dominant hearing loss (DFNA2); gene defects in K v 7.2 or K v 7.3 are responsible for Benign Familial Neonatal Seizures (BFNS), an inherited epilepsy of the newborn (Miceli et al., 2008; Brown and Passmore, 2009 ).
In addition to neural tissue, K v 7.4 and K v 7.5 expression has been described also in smooth muscle cells from several vascular beds, where they control reactivity to vasopressors (Yeung et al., 2007; Mackie et al., 2008) . In addition, K v 7.1 (Tsevi et al., 2005) and K v 7.5 (Lerche et al., 2000; Schroeder et al., 2000) transcripts have been detected in adult skeletal muscle; changes in K v 7.1 and K v 7.5 transcript levels occur during proliferation and differentiation of rat L6E9 myoblasts in vitro (Roura-Ferrer et al., 2008) . However, no data is yet available on other K v 7 family members; moreover, the functional role of K v 7.1 and K v 7.5 in skeletal muscle is still poorly defined.
In this study, using murine C 2 C 12 cells as an experimental model for in vitro skeletal myogenesis, we have investigated the expression pattern of K v 7.1-5 transcripts and proteins during skeletal muscle differentiation. Moreover, the expression of K v 7 subunits in adult skeletal muscle from mouse and humans, as well as their possible role in C 2 C 12 cell proliferation, differentiation, and protection from drug-induced myotoxicity, has also been investigated. To this aim, channel blockers (XE-991) and activators (retigabine) of Kv7 channels (Miceli et al., 2008) were used. The results obtained indicate that neural K v 7 channels regulate skeletal muscle cell proliferation, differentiation, and response to myotoxic stimuli, thus highlighting novel potential therapeutic opportunities for K v 7 channel modulators in skeletal muscle disorders including drug-induced myopathies.
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Supplemental Table 1 for primer sequences), and 5U/μl Amplitaq Gold (Applied Biosystem, Monza, Italy). The protocol used for PCR amplification was the following: denaturation at 95°C for 1 min, annealing at 54-60°C (template-dependent) for 1 min, elongation at 72°C for 1 min (35 cycles, one every 13 min). To test the ability of the Kv7 primers to specifically recognize the mRNA target against which they were designed, RT-PCR experiments were performed using cDNA templates from adult mouse brain and heart mRNAs (Supplemental Fig. 2 ). Neural K v 7.2-Kv7.5 transcripts were effectively detected in brain tissue (left panel); a very faint band corresponding to K v 7.1 mRNA could also be identified, consistent with previous results (Ohya et al., 2003; Yeung et al., 2007) . Moreover, in mouse heart, only K v 7.1 and K v 7.4 transcripts (the latter of presumed vascular origin) showed significant expression (right panel).
Quantitative real-time PCR was carried out in a 7500 fast real-time PCR system (Applied Biosystem, Monza, Italy) using the K v 7 primers using SYBR Green detection. Samples were amplified simultaneously in triplicate in one assay run, and the ct (threshold cycle) value for each experimental group was determined. Data normalization was performed using as control the ct from S16, a constitutively-expressed ribosomal protein; differences in mRNA content between groups were calculated as normalized values using the 2 -Δct formula.
CELL PROLIFERATION. To assess C 2 C 12 cell proliferation, myoblasts were trypsinized and seeded onto 24-well plastic plates at a 2x10 3 cells/cm 2 density. After adhesion, the cells were synchronized in DM for 30h; cells were then washed twice with phosphate buffered saline (PBS), and 1μCi/ml of [methyl-3 H] thymidine (GE Healthcare, Milan, Italy) was added in fresh GM or DM medium containing the drug(s) of interest. After 24h, the cells were fixed in cold methanol, washed three times in ice-cold 10% trichloracetic acid, and solubilised in 1% SDS and 0.3% NaOH (Roura-Ferrer et al., 2008) . The radioactivity in each sample was determined by liquid scintillation counting in a were taken to minimize animal suffering and to use the minimum number of animals necessary to obtain reliable results. Animals were deeply anesthetized, perfused with saline (10 ml) followed by 50 ml of freshly-made paraformaldehyde (4% w/v in PBS). From these animals, soleus muscles were removed and post-fixed in the same fixative for 2 h at 4°C, and washed with 0.1 M glycine for 5-10 min. Mouse or fixed human tissue was cut with a cryostat into 20 μm thick sections which were mounted onto pre-treated Superfrost slides, stored at -80°C until further processing. Mouse and human sections were incubated overnight at 4°C with the following primary antibodies: a) transcripts whose skeletal muscle expression has been previously described (Roura-Ferrer et al., 2008) , those encoding for K v 7.2, K v 7.3, and K v 7.4 were also detected in C 2 C 12 myoblasts cultured in growth medium (GM) ( Table 1 (Table 1 and Fig. 1A ). The fact that Kv7 genes appear as the only the ion channel subclass whose mRNAs can be detected in C2C12 myoblasts and whose transcript levels are increased upon myotube formation, is suggestive of their potential role during skeletal myogenesis.
Since the RT-PCR technique does not allow one to quantify in absolute terms the extent of gene expression changes, quantitative real time PCR experiments, using a relative-comparative method, were performed; this technique, by comparing the cycle-dependent increase in the relative fluorescence of the amplified product, allows one to define, for each experimental condition, a cycle threshold (ct); this parameter is then normalized to the ct value of a constitutive gene (S16) whose expression does not change during the experimental procedures, thus defining a Δct value (Fig 1B) . To evaluate the expression of the proteins encoded by the K v 7.2, K v 7.3, and K v 7.4 mRNAs herewith described for the first time, Western-blot analysis using subunit-specific antibodies were performed in cell lysates from C 2 C 12 myoblasts and myotubes (72 hours of DM exposure) (Fig. 2 ).
Comparison of
Antibody specificity was tested in parallel Western-blot experiments using membrane fractions (Fig. 3A) . Furthermore, confocal immunofluorescence experiments on mouse skeletal muscle cryosections revealed that K v 7.2 and K v 7.3 immunofluorescence was mainly associated with intracellular striations; in addition, Kv7.2, but not Kv7.3, immunofluorescence also appeared to be expressed along the sarcolemmal membrane. By contrast, K v 7.4 immunoreactivity appeared to be exclusively localized at the level of the plasma membrane (Fig. 3B ). To gain further insight into the subcellular localization of K v 7.2, K v 7.3 and K v 7.4 subunits, experiments were performed using antibodies against Ankyrin-G (AnkG), a scaffold protein localized within the sarcoplasmic reticulum in adult skeletal muscle fibers (Kordeli et al., 1995; Kordeli et al., 1998) ; in these experiments, the nuclear marker chromomycin A3 was also used. In longitudinal sections, AnkG immunofluorescence was associated with both the sub-plasmalemmal region of the sarcomere and its intracellular striations, This article has not been copyedited and formatted. The final version may differ from this version. labelling two bands per sarcomere. Each of these bands is likely to correspond to a triad running on each side of a Z-line; within each triad, AnkG has been shown to be concentrated along plasmalemmal T-tubules (Flucher et al., 1990) . A similar distribution pattern has been shown for ryanodine receptors-1 (RyR-1) (Salanova et al., 2002) . In the same sections, Kv7.2-and Kv7.3-positive striations were thin and non-overlapping with those recognized by anti-AnkG antibodies, being instead positioned between each pair of thick AnkG-labeled triads; these results suggest the possible expression of Kv7.2 and Kv7.3 subunits in a sarcomeric pattern at the level of the Z-line.
While Kv7.2 and Kv7.3 exhibited intracytoplasmic immunoreactivity, K v 7.4 immunostaining did not co-localize with AnkG at the cytoplasmic level, being only detected along the plasmalemmal membrane, as also revealed by the subsarcolemmal position of the myotube nuclei.
In human skeletal muscle, K v 7.2, K v 7.3, and K v 7.4 mRNAs were detected by RT-PCR (Fig.   3C ); moreover, an expression pattern similar to that previously described in mouse muscle tissue was observed with confocal immunohistochemistry (Fig. 3D) (Wang et al., 1998) . Proliferation was measured by 3 H-thymidine incorporation, whereas differentiation was quantified by the transcripts levels of myogenin, a muscle-specific transcription factor required for myotube formation (Bennett and Tonks, 1997) . RT (10 μM) reduced C 2 C 12 myoblasts proliferation to values similar to those observed in cells exposed to DM. The K v 7 blocker XE-991 (10 μM) failed to interfere with C 2 C 12 cell proliferation, although it prevented the inhibitory effect exerted by RT (Fig. 4A) . In RT-PCR experiments, RT (10 μM) increased the mRNA expression level for myogenin after 24 and 48 hours of cell exposure to DM, an effect prevented by XE-991 (10 μM) (Fig. 4B) ; similar results were also obtained with real-time PCR experiments (data not shown). These results suggest that the reduced C2C12 myoblasts proliferation caused by RT may be attributed, at least in part, to an enhanced or anticipated differentiation of myoblasts into myotubes triggered by the pharmacological activation of neural Kv7 channels.
This article has not been copyedited and formatted. The final version may differ from this version. (Baba et al., 2008) , an effect opposite to that prompted by neural K v 7 channel activation in the present experiments, the consequences of the pharmacological manipulation of K v 7 channels on C 2 C 12 myoblast viability after exposure to mevastatin (MEV) were evaluated. When proliferating C 2 C 12 myoblasts were exposed to MEV (0.1-100 μ M), a dose-and time-dependent reduction in cell viability was observed. The IC 50 for MEV-induced toxicity was time-dependent, being ~20 μM after 24 hrs, ~6
μM after 48 hours, and ~2 μM after 72 hours of drug exposure (Fig. 5A) . When compared to myoblasts, differentiated C 2 C 12 myotubes appeared considerably less sensitive to statin-induced toxicity; in fact, the percent of survival after exposure to 3 μM MEV for 48 hours was 57.5±4.4%
(n=8) and 93±6% (n=4) in myoblasts and myotubes, respectively (p<0.05); even more dramatic differences were observed when MEV concentrations were increased to 100 μM (cell survival was 16±0.5%, n=6, and 75±4%, n=5, in C 2 C 12 myoblasts and myotubes, respectively; p<0.05). The potential myoprotective actions of K v 7 modulators was assessed upon simultaneous incubation of proliferating C 2 C 12 cells with RT, XE-991, and RT+XE-991 together with 3 μM MEV for 48 hours, a value close to the calculated EC 50 for the statin. RT (1-100 μM) dose-dependently and fully protected C 2 C 12 cells from MEV-induced cytotoxicity; the IC 50 for RT-induced myoprotection was ~7 μM (Fig. 5B) . At each time point (24, 48, and 72 hours), XE-991 (10 μM; Fig. 5C ) counteracted the protective effect of RT on MEV-induced toxicity, strongly suggesting that the K v 7-activating potential of the drug was responsible for this pharmacological action.
This article has not been copyedited and formatted. The final version may differ from this version. -dependent myoblast acquisition of fusion competence (Bijlenga et al., 2000) .
In order to identify additional ion channels which might participate in the early phases of skeletal muscle development, an extensive analysis of the changes in the expression levels of an array of ion channel transcripts during in vitro C 2 C 12 myoblasts differentiation into myotubes was striated muscle structure and function, and showing a crucial role in the pathogenesis of human skeletal muscle myopathies (Sheikh et al., 2007 RT activates with different apparent affinity homomeric or heteromeric channels formed by K v 7 neural subunits, but is unable to potentiate the currents carried by cardiac K v 7.1 channels. RT enhances neural K v 7 currents by causing an hyperpolarizing shift of the voltage-dependence of activation and/or by increasing the maximal amount of current elicited by strong depolarizations (Miceli et al., 2008) . In the present study, RT markedly reduced C 2 C 12 myoblast proliferation and enhanced myotube formation, possibly because the drug enhanced the contribution of K v 7 channels to C 2 C 12 membrane potential control, thereby rendering more negative the cell membrane potential, a phenomenon known to facilitate skeletal muscle differentiation and halt cell proliferation (Wieland and Gong, 1995; Bijlenga et al., 1998; Bijlenga et al., 2000; Fischer-Lougheed et al., 2001 ). Noticeably, K v 7.1, K v 7.3, and K v 7.4 transcripts appear to be up-regulated at a differentiation stage at which K v 10.1 transcripts show a decreased expression (Table 1) ; the down-regulation of the K v 10.1 channel results in an hyperpolarization to ~-65 mV of the membrane potential of myoblasts as a result of the major remaining influence of K IR channels; this would permit an enhanced impact of subthreshold K v 7 channels under moderately depolarizing conditions.
It should be mentioned that, in addition to activating neural K v 7 channels, RT also affects other voltage-and ligand-gated channels; however, these pharmacological actions require concentrations higher than those used in the present study (Rundfeldt and Netzer, 2000) . Moreover, the fact that XE-991 fully counteracted RT-induced effects on C 2 C 12 cell proliferation and differentiation strongly suggests that neuronal K v 7 channels act as molecular targets for RT. While blocker XE-991. This result is apparent contrast with that of Roura-Ferrer et al. (2008) showing that the IKM blocker linopiridine caused a 60% reduction of C 2 C 12 cell proliferation. However, in this study, linopiridine was used at a concentration (100 μM) which does not discriminate among voltage-gated potassium channel subfamilies (Wang et al., 1998) ; therefore, further experiments are needed before this pharmacological effect may be attributed to a selective involvement of K v 7 channels.
Several plausible explanations might be given to interpret the inability of XE-991 to interfere with C 2 C 12 cell proliferation and differentiation in the present experiments. The first is that K v 7 channels only contribute to a limited amount of outward current, and therefore their blockade does not significantly influence C 2 C 12 cell membrane potential. The fact that K v 7 channels are not strongly active at the resting membrane potential, but only become so when activated by RT, has already been described in peripheral un-myelinated C-type nerve fibers (Lang et al., 2008) and pain, possibly associated to plasma creatine kinase elevation is among the rare but potentially severe toxicities associated with statins, widely-prescribed lipid-lowering agents acting as HMGCoA reductase inhibitors (Sirvent et al., 2008) . Despite the widespread concern over this clinicallyrelevant side effect, knowledge of its molecular pathogenesis is still a matter of debate; statins have been reported to affect mitochondrial function, thereby leading to a Ca 2+ leak that directly interferes with the regulation of sarcoplasmic reticulum Ca 2+ cycling (Klopstock, 2008; Sirvent et al., 2008) . view of the fact that, when compared to myotubes, myoblasts appear significantly more sensitive to mevastatin-induced myotoxic actions, an important role seems to be attributable to the ability of RT to promote C 2 C 12 cell differentiation and withdrawal from the cell cycle, an effect opposite to that prompted by statins in the same cells (Baba et al., 2008) .
Collectively, the present results indicate that the pharmacological activation of neural K v 7 subunits regulates skeletal muscle cells proliferation, differentiation, and survival after myotoxic stimuli, thus revealing a novel role for these channels as potential therapeutic targets in druginduced myopathies. Moreover, myoprotective effects triggered by the pharmacological activation of neural K v 7 subunits may be of clinical relevance also in other skeletal muscle disorders; the RT structural analogue flupirtine, a non-opioid analgesic which also acts as a neural K v 7 channel opener (Miceli et al., 2008) , appears effective against different types of musculoskeletal pains (Friedel and Fitton, 1993) , and displays significant skeletal muscle-relaxing effects in humans (Lobish et al., 1996) . It remains to be investigated whether, in addition to its effects on neural sensory information processing, flupirtine-induced opening of K v 7 channels at the skeletal muscle level is also involved in these pharmacological effects.
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